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1 Zusammenfassung 
Wachstum und Metastasierung von Krebszellen werden stark durch das umgebende Krebs-assoziierte 
Stroma (CAS) beeinflusst. Eine wichtige zelluläre Komponente dieses CAS sind die sogenannten Krebs-
assoziierten Fibroblasten (CAFs). CAFs fördern sowohl Wachstum als auch Metastasierung von 
Tumoren, und sind deshalb interessante Zielstrukturen für therapeutische Ansatzpunkte. 
Entzündungsmediatoren wie transforming growth factor β (TGF β), und/oder reaktive 
Sauerstoffradikale (ROS) können die Aktivierung von CAFs induzieren. Jedoch sind der exakte 
Mechanismus zur Entstehung von CAFs sowie deren Effekte auf die Tumorzellen noch nicht komplett 
verstanden. Die Basen-exzisions Reparatur (BER) ist ein DNA Reparaturmechanismus, welcher für den 
Erhalt der zellulären Genomintegrität von höchster Relevanz ist. Eine Depletion des zentralen BER 
Proteins XRCC1 durch knockdown (KD) führt zu persistierenden DNA Schäden, welche 
Genexpressions-Veränderungen induzieren die vergleichbar sind mit denen in Tumorzellen. Wir 
haben kürzlich gezeigt, dass TGF β und ROS in Fibroblasten persistierende DNA Schäden durch 
Herunterregulierung von XRCC1 hervorrufen. Dies führt wiederum zu einer Aktivierung von CAFs, 
welche in vitro Wachstum und Motilität von Tumorzellen unterstützen. Diese Umprogrammierung ist 
weitgehend vom Stress-induzierten Transkriptionsfaktor ATF4 abhängig, und scheint metabolische 
Veränderungen zu verursachen, welche möglicherweise die zelluläre Nährstoff-Selbstversorgung 
verbessert. Jedoch ist der Zweck dieser Umprogrammierung durch Herunterregulierung von XRCC1 
noch völlig unklar. Des Weiteren haben wir gezeigt, dass ein stromaler XRCC1 KO in vivo verstärktes 
Tumorwachstum und –Metastasierung auslöst. Basierend auf diesen Ergebnissen war das Ziel dieses 
Projektes die Untersuchung der folgenden zwei Hauptfragestellungen: 
1. Führen die XRCC1 KD-induzierten metabolischen Veränderungen zu einem Überlebensvorteil bei 
eingeschränkter Nährstoffversorgung? Und wenn ja, ist dies abhängig von ATF4? 
2. Welche molekularen Veränderungen geschehen im CAS von XRCC1 KO Mäusen? Wie 
Unterstützen diese Veränderungen Tumorwachstum und Metastasierung? 
Um zu untersuchen, ob die XRCC1 KD-induzierten metabolischen Veränderungen in einem Vorteil bei 
eingeschränkter Nährstoffversorgung resultieren, wurden die Zellen in unterschiedlichen Serum 
(FCS)-konditionen kultiviert. Während keine Unterschiede bei 5% FCS zu verzeichnen waren, hatten 
XRCC1 KD Zellen einen klaren Wachstums- und/oder Überlebensvorteil bei 1% FCS. Dieser war 
abhängig von ATF4. Da die Zellproliferation von XRCC1 KD Zellen sich hierbei nicht von der Kontrolle 
unterschied, ist die höhere Zellzahl bei 1% FCS höchstwahrscheinlich das Resultat erhöhter Resistenz 
gegenüber Apoptose.  
Um XRCC1 KO-induzierte stromale Genexpressionsveränderungen zu identifizieren, wurde RNA von 
CAS und normalem Stroma mittels Laser-Mikrodissektion gefrorener Tumoren unseres Mausmodells 
extrahiert. Next-generation Sequenzierung enthüllte klare Unterschiede in CAS und normalem Stroma 
von XRCC1 KO verglichen mit Kontrollmäusen, welche möglicherweise das erhöhte Tumorwachstum 
und die Metastasierung erklären können.  
Zusammenfassend zeigen wir, dass ein Mangel an XRCC1 zum Überleben von CAFs bei 
eingeschränkter Nährstoffversorgung in vitro beiträgt, und identifizieren molekulare Veränderungen, 
die möglicherweise zu Tumorwachstum und Metastasierung in vivo beisteuern. Verbessertes 
Verständnis der Umprogrammierung von CAFs und deren Effekte auf Tumorzellen trägt zum 
vertieften Verständnis der Grundlagenbiologie von Krebserkrankungen bei, und hat das Potenzial 
neuartige therapeutische Strategien zu enthüllen.  
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2 Summary 
Cancer growth and metastasis is strongly influenced by the surrounding cancer-associated stroma 
(CAS). A prominent cellular component of CAS are the so-called cancer-associated fibroblasts (CAFs) 
which strongly support tumour growth and metastasis, and thus present an interesting target for 
therapeutic intervention. It is known that inflammatory cytokines, such as transforming growth factor 
β (TGF β) and/or reactive oxygen species (ROS) can induce activation of CAFs. However, the exact 
mechanism by which CAFs are induced and the effects they exert on tumour cells remain far from 
being completely understood. Base excision repair (BER) is a centrally important DNA repair 
mechanism in cells responsible for the maintenance of genome integrity. Depletion of the core BER 
protein XRCC1 by knockdown (KD) leads to persistent DNA damage, which induces gene-expression 
changes comparable to those found in tumours. We have recently found that TGF β and ROS induce 
persistent DNA damage in fibroblasts through down-regulation of XRCC1, which leads to activation 
of CAFs that support growth and motility of tumour cells in vitro. This reprogramming is largely 
dependent on the stress-responsive transcription factor ATF4, and seems to induce a metabolic 
rewiring that might increase nutritional self-sufficiency. However, the rationale for this 
reprogramming through XRCC1 downregulation remains enigmatic. Furthermore, we have discovered 
that a stromal XRCC1 knockout (KO) triggers increased tumour growth and metastasis in vivo. Based 
on these findings, the aim of this project was to investigate the following two main questions: 
1. Do the XRCC1 KD induced metabolic changes in fibroblasts promote survival in conditions of 
restricted nutrient supply? If yes, is this dependent on ATF4? 
2. What molecular changes can be observed in CAS of XRCC1 KO mice? How do these changes 
support tumour growth and metastasis? 
To investigate whether the XRCC1 KD-mediated metabolic rewiring resulted in an advantage under 
nutrient-restricted conditions, cells were grown in different serum (FCS)-restricted conditions. While 
no differences were found in cells grown at 5% FCS, XRCC1 KD conferred a very clear growth and/or 
survival advantage at 1% FCS. This advantage was dependent on ATF4. As cell proliferation in XRCC1 
KD cells did not differ from control cells, the higher cell number at 1% FCS is likely due to an increased 
cellular resistance to apoptosis.   
To identify XRCC1 KO-induced stromal gene expression changes, we extracted RNA from CAS and 
normal stroma from fresh-frozen tumours derived from our mouse model using laser-capture 
microdissection. Next-generation sequencing revealed clear differences in CAS and normal stroma 
from XRCC1-KO compared to control mice, which could possibly explain the increase of tumour 
growth and metastasis that were observed.  
In summary, we demonstrate that an XRCC1 deficiency contributes to increased survival of CAFs 
under nutrient-restricted conditions in vitro, and identify molecular changes that possibly promote 
tumour growth and metastasis in vivo. Better understanding of the reprogramming and the effects of 
CAFs will further our understanding of basic tumour biology and have the potential to unveil novel 
therapeutic strategies.  
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3 Abbreviations 
AP site abasic site  
APE1 AP-endonuclease 1  
ATF4 activating transcription factor 4 
BER base excision repair 
CAF cancer-associated fibroblasts 
CAS cancer-associated stroma 
FCS fetal calf serum 
ISR integrative stress response  
KD knockdown 
KO knockout 
LCM laser-capture microdissection 
Lig III DNA ligase IIIa 
LLC Lewis Lung Carcinoma 
NGS next-generation sequencing  
OCT optimal cutting temperature compound  
Pol β DNA polymerase β  
RIN RNA integrity number 
ROS reactive oxygen species 
RT-qPCR quantitative real-time PCR  
SSB single strand break 
TGFβ transforming growth factor β 
XRCC1 X-ray repair cross complementing 1 
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4 Introduction 
4.1 Cancer and cancer-associated stroma 
The term “cancer” stands for a large group of diseases that can occur anywhere in the body. Common 
to all cancers is the rapid growth of abnormal cells, which is often coupled with the ability to invade 
and metastasise [1]. In the 21st century, cancer is expected to rank as the leading cause of death and the 
most important barrier to increasing life expectancy in every country of the world [2]. 3.91 million new 
cases (excluding non-melanoma skin cancer) and 1.93 million deaths from cancer were estimated in 
2018 in Europe alone [3]. These facts highlight the importance to better understand the driving and 
supporting mechanisms of cancer growth, to then develop better treatments.  
Historically, cancer has been viewed as a disease only depending on the abnormally growing tumour 
cells themselves. However, more recent research has clearly shown, that cancer growth and metastasis 
is strongly influenced by the surrounding non-cancerous tissue termed cancer-associated stroma (CAS). 
That is why, over the past decades, there has been a growing attention for the role of CAS in cancer 
research [4, 5]. In general, CAS consists of the non-malignant cells and their stroma within and around 
a tumour [4, 6]. Among other stromal components such as immune cells, angiogenic vascular cells, and 
extracellular matrix, one prominent cellular component of CAS are the fibroblasts, which display an 
activated phenotype, resembling the one found during wound healing [6]. Unlike normal fibroblasts, 
these so-called cancer-associated fibroblasts (CAFs) are not quiescent and supportive cells, but instead 
are proliferative, migratory and highly secretory [4]. They encourage and support tumour growth, 
angiogenesis, inflammation and metastasis and are therefore a major factor influencing tumour 
outcome [7]. It is known that inflammatory cytokines, such as transforming growth factor β (TGF β), 
and/or reactive oxygen species (ROS) can induce the activation of CAFs from normal fibroblasts [8, 9]. 
However, the underlying molecular mechanisms that drive CAF formation through TGF β or ROS 
remain unclear. 
Despite the increase in possible therapeutic options, most of the available modalities set their focus on 
the malignant cancer cells without considering the surrounding non-cancerous part, the CAS. Given 
that cancer cells do not manifest the disease alone, but strongly depend on the normal surrounding 
cells of CAS, addressing the CAS in its molecular details is an important and promising aspect to 
identify targets for the development of novel therapeutic approaches. 
 
4.2 The link between base-excision repair and cancer-associated fibroblasts 
Mutations in the DNA sequence are considered the molecular origin of the vast majority of cancers. 
They can occur due to DNA damage, caused by various exogenous sources. But even without 
exogenous influence DNA is prone to spontaneous alterations, due to its chemical reactivity in the 
aquatic milieu [10]. 
Base excision repair (BER) is a centrally important DNA repair mechanism in cells that is responsible 
for the maintenance of genome integrity, and the avoidance of mutagenic and cytotoxic consequences  
[11, 12]. It corrects small base lesions and DNA single strand breaks (SSBs), that occur due to different 
endogenous or exogenous mutagens or the intrinsic chemical instability of the DNA molecule [10, 12]. 
The entire BER process is well studied and the major players involved have been known for a long time 
[12]. Mechanistically, BER can be roughly subdivided into the following steps: i) once a corrupted base 
occurs, it is recognised and released by damage-specific DNA glycosylases. ii) The arising abasic site 
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(AP site) is further processed by AP-endonuclease 1 (APE1), which cleaves the DNA sugar-phosphate 
backbone at 5’ to the AP site, thus generating a SSB. iii) This SSB is substrate to a protein complex 
consisting of DNA polymerase β (Pol β), XRCC1 and DNA ligase IIIa (Lig III), which catalyses the 
addition of the missing nucleotide and seals the DNA ends, thereby restoring a fully double-stranded 
DNA [10, 12]. BER is a highly coordinated process, with the scaffold protein XRCC1 as a crucial factor, 
due to its ability to stabilise Pol β and Lig III. Thus, cells deficient in XRCC1 display reduced DNA 
repair and an increase in genomic instability [10, 12, 13].  
It was shown that persistent DNA damage, induced through a downregulation of XRCC1 by siRNA in 
human primary fibroblasts, can induce gene-expression changes that are comparable to those found in 
tumours [10]. Furthermore, it was found that prolonged exposure to the pro-inflammatory cytokine 
TGF or ROS causes a deficiency in BER by down-regulating XRCC1 expression in primary fibroblasts 
[14]. Importantly, this resulted in a decreased BER capacity and persistent DNA damage, that in turn 
induced normal fibroblasts to assume a CAF-like phenotype capable of supporting growth and motility 
of tumour cells through the secretion of soluble stimulating factors in vitro. This reprogramming was 
found to be at least partially dependent on the stress-responsive transcription factor ATF4 [10, 14].  
Taken together, these results suggested that the down-regulation of BER capacity through a decrease 
in XRCC1 expression in fibroblasts as a generalised reaction to stressful conditions might also play a 
role in tumour formation in vivo by inducing a more pro-tumorigenic stromal environment.  
Based on these findings, the Markkanen lab decided to investigate, whether persistent DNA damage 
in stromal fibroblasts can trigger an increase in tumour growth and metastasis in vivo. Importantly 
however, a knockout (KO) of XRCC1 in the whole mouse is embryonically lethal, presumably through 
accumulation of unrepaired DNA damage, which is not compatible with physiological development 
[15, 16]. Therefore, a mouse model in which the expression of XRCC1 could be abrogated specifically 
in the stromal cell compartment was developed. To this end, C57Bl6-XRCC1loxP/loxP mice were crossed 
with C57Bl6-Col1a2-CreER mice. The latter are mice in which Cre expression is specific for stromal 
fibroblast and induced just upon administration of Tamoxifen, which makes it possible to delay the KO 
of XRCC1 until after birth, so eventual complications caused by the KO during embryonic development 
could be further reduced. Therefore, the XRCC1loxP/loxP Col1a2-CreER model allows a specific deletion 
of XRCC1 in stromal fibroblasts in mice post natum. Using these mice, the growth and metastasis of 
luciferase labelled syngeneic tumour cells injected s.c. was analysed using a combination of IVIS in vivo 
imaging and histopathology. Yet unpublished data demonstrates that a conditional deletion of XRCC1 
in fibroblasts triggers an increase in both primary tumour growth as well as metastasis in vivo (Clementi 
et al, unpublished data).  
As mentioned above, lengthened exposure to pro-inflammatory cytokines and ROS have been 
identified to induce a deficiency in BER through transcriptional down-regulation of XRCC1, which in 
turn leads to CAF activation through this exhaustion of the BER pathway [14]. But what is the rationale 
of this down-regulation of XRCC1 in fibroblasts under stressful circumstances? In order to answer this 
question, recent results from a metabolic analysis of XRCC1-depleted primary human fibroblasts have 
revealed vast metabolic adjustments that cause cellular metabolism to shift towards the use of the one-
carbon cycle or the pentose phosphate pathway, and away from the use of the TCA cycle (Legrand et 
al, unpublished observations). Interestingly, these changes increase cellular self-sufficiency with 
respect to many metabolites, such as nucleotides, amino acids and energy. Of note, this metabolic 
rewiring was found to depend on ATF4. ATF4 is a transcription factor tightly involved in a process 
termed integrative stress response (ISR) [17]. In this context, in response to a variety of different stresses, 
ATF4 induces the expression of a multitude of genes involved in anabolic metabolism, such as nutrient 
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uptake, amino acid metabolism, and anti-oxidative responses. Per definitionem, CAFs are located closely 
adjacent to the epithelial tumour-forming, rapidly dividing cancer cells. These cancer cells have a huge 
demand in a wide variety of nutrients to sustain their high proliferative rate, and they have been shown 
to remodel the surrounding stroma in a way that increases the delivery of such nutrients and other 
growth-promoting molecules [5]. Specifically, CAFs have been found to take up metabolic waste of 
cancer cells to produce metabolites that in turn are secreted again to feed the tumour [18]. It is thus 
thought that most of the ‘rich’ nutrients are drained away from CAFs to support tumour growth, which 
results in the necessity for CAFs to survive in a ‘starved’ environment. The observed down-regulation 
of BER capacity in fibroblasts exposed to a maintained pro-inflammatory stimulation that induces CAF 
generation seems to thus increase self-sufficiency of these cells, which would be beneficial in a starved 
environment. In summary, emerging evidence strongly suggests that CAF activation through 
prolonged pro-inflammatory stimulation results in a BER decline. Similarly, CAF activation can be 
achieved simply through depletion of BER capacity through down-regulation of XRCC1. Finally, the 
decline in BER capacity results in an ATF4-mediated vast metabolic reprogramming which in turn seem 
to support nutritional self-sufficiency of CAFs.  
 
4.3 Specific analysis of cancer-associated stroma through laser-capture 
microdissection and analysis by next-generation sequencing 
To specifically analyse CAS from clinical tumour samples, we have recently established isolation of 
CAS and matched normal stroma from tumour specimen by laser-capture microdissection (LCM) 
coupled with next-generation sequencing (NGS) [19, 20]. LCM is a technique that allows selective 
isolation of microscopic areas of interest from tissue sections [21]. The tissue subsections that were 
isolated can then be further used to extract macromolecules, such as RNA, to interrogate the underlying 
molecular events, for instance through NGS. NGS is a highly valuable method that allows high-
throughput analysis of gene expression patterns in samples of interest in large detail. Thus, LCM 
coupled with NGS allows the detailed analysis of areas of interest from animal and human tissue 
sections.  
 
4.4 Aims of the project 
Recent progress has started to unveil the importance of CAFs in the formation and progression of 
cancer. However, the exact mechanism, by which CAFs are induced and the effects they exert on 
tumour cells remain far from being completely understood. We have recently found that persistent 
DNA damage brought about through either pro-inflammatory cytokines or the depletion of XRCC1 in 
fibroblasts leads to the emergence of a CAF-like phenotype in vitro. This reprogramming is largely 
dependent on ATF4, and seems to induce a metabolic rewiring that promotes nutritional self-
sufficiency of these cells. Furthermore, we have discovered that stromal XRCC1 deletion triggers an 
increase of tumour growth and metastasis in vivo. Based on these findings, the aim of this project was 
to investigate the following two main questions: 
 
1. Does XRCC1 depletion in fibroblasts induce changes that support their survival in restricted growth 
conditions? If yes, is this dependent on the stress-responsive transcription factor ATF4? 
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2. What molecular changes can be observed in the tumour stroma of mice with a stromal XRCC1 
depletion? How do these changes support tumour growth and metastasis? 
 
In summary, the main aims of this project were to unveil how an XRCC1 deficiency contributes to 
growth and survival of CAFs in vitro, and to shed light on how it promotes tumour growth and 
metastasis in vivo. Better understanding of the reprogramming and the effects of CAFs will further our 
understanding of basic tumour biology and have the potential to unveil novel therapeutic strategies. 
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5 Material and Methods 
5.1 Analysis of cancer-associated stroma from the mouse model 
5.1.1 Cryo laser-capture microdissection 
5.1.1.1 Origin of tissue 
Conditional XRCC1 KO in fibroblasts – The tissue samples for this experiment came from a mouse 
model with fibroblast-specific KO of XRCC1 induced through a Tamoxifen-inducible Cre/loxP 
approach [22]. Shortly after weaning at 3 weeks post natum, experimental (Col1a2-Cre Tg/+, XRCC1 
Tg/Tg) and control (Col1a2-Cre Tg/+, XRCC1 wt/wt or Col1a2-Cre +/+, XRCC1 Tg/Tg) male mice were 
fed a Tamoxifen diet (Tamoxifen Lab Animal Diet (TD.07262; 400 mg tamoxifen citrate per kg diet; 
Harlan Laboratories)) for 4 weeks continuously to induce the KO in the experimental mice or to control 
for the effect of Tamoxifen and Cre expression alone in control mice. After completion of this diet, mice 
were put back on standard diet for at least two weeks before starting with the injection of tumour cells. 
 
Tumour cell injection – 1-10 x 10e6 Luciferase-labelled Lewis Lung Carcinoma (LLC) murine tumour 
cells in 0.15 ml PBS were implanted subcutaneously into the shaved lower back of the mice on the right 
side. For this procedure mice were anesthetised with isoflurane. 
 
Tumour resection – After 3 to 4 weeks, when the primary tumours reached a size of maximally 1.5 cm 
diameter, the tumours were surgically resected. The excised tumours were cut in half, with one half 
being fresh frozen for subsequent isolation of stroma through laser-capture microdissection (as detailed 
below), and the other half undergoing formalin fixation for histopathological analyses 
 
Samples of normal skin – When the mice were sacrificed under anaesthesia, around 3 weeks after the 
excision of the primary tumour, a small piece of skin from the back of the mouse on the side opposite 
of the primary tumour was excised and immediately fresh-frozen. This skin was considered as healthy, 
non-tumour affected stroma. 
 
5.1.1.2 Fresh-freezing of tissue specimen 
Liquid nitrogen was poured in a styrofoam container and a can filled with isopentane placed in it. The 
excised tissue was put in a bucket formed out of aluminium foil with a layer of optimal cutting 
temperature compound (OCT) (Cellpath™) at the bottom and then covered with OCT completely. The 
aluminium bucket with the tissue inside was then immersed into the isopentane with wooden tweezers. 
Before the can containing the isopentane would start to freeze, it was taken out of the liquid nitrogen 
with the aluminium bucket still in it. When the OCT was frozen completely (recognised through a 
change of colour from clear to milky) the bucket was removed, and the frozen tissue block was wrapped 
in aluminium foil and stored in -20°C until all samples had been collected. Afterwards, the tissue blocks 
were stored at -80°C until needed. 
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5.1.1.3 Slide preparation 
Fresh frozen samples were taken out of -80°C and transported to the Institute of Veterinary Pathology 
Zürich on dry ice for histologic processing. The samples were mounted on OCT in a microtome-cryostat 
and cut to 10 µm sections. All the equipment was treated with RNAse AWAY® (Molecular 
BioProductsTM). The sections were mounted on Arcturus® PEN Membrane Glass Slides (Applied 
Biosystems™), two sections per slide.  
To get an overview of the tissue section for microdissection, one section was mounted on a normal glass 
slide and stained with H&E staining. The unstained slides were put in a box with dry ice to bring them 
back to the lab, where the slides were stored in a box in -80°C until microdissection. According to the 
Arcturus “Optimized Protocol for Preparing and Staining LCM Samples from Frozen Tissue and 
Extraction of High-Quality RNA” handbook, the mounted sections can be stored for up to two months 
in -80°C, so all the samples for the following week were cut on Monday and stored till the day they 
were needed, without recognisable harm. 
 
5.1.1.4 Staining and laser-capture microdissection (LCM) 
Frozen tissue sections were transported on dry ice. One slide per time was taken out and left one minute 
to adjust to room temperature. Then it was stained with Cresyl Fast Violet according to the following 
protocol (Table 1) using Cresyl violet (acetate) for microscopy Certistain® and ethanol (Honeywell 
Riedel-de Haën). 
 
95% ethanol 30 sec 
75% ethanol 30 sec 
Cresyl violet (75% ethanol with dH2O) 40 sec 
75% ethanol 30 sec 
95% ethanol 30 sec 
100% ethanol 30 sec 
100% ethanol 30 sec 
100% ethanol 5 min 
Table 1: Staining protocol for fresh frozen tissue sections 
 
The ArcturusXT™ Laser Capture Microdissection System (Thermo Scientific) and Arcturus® 
CapSure® Macro LCM Caps (Life Technologies) were used for microdissection according to the 
manufacturer’s protocol.  
Photographic documentation of the microdissection process was performed throughout the whole 
process (see Figure 1, Figure 2). To verify the specificity of the isolation procedure, both the area of 
interest and the isolated tissue on the cap were reviewed after excision (Figure 11 and Figure 12). 
 
Isolation of tumour stroma – Tumour stroma for isolation was identified with the help of a pathologist. 
Stroma inside the tumour and within a range of 2 mm around the tumour was collected, avoiding areas 
with heavy inflammation, glands, hair follicles, fat and muscle cells. Since the tumours contained little 
stroma, three slides with two sections each were used to fill one Cap.  
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Isolation of normal stroma from skin – Normal stroma was collected from two slides with two sections 
each. Similar to the tumour samples, glands, hair follicle, fat and muscle cells were avoided as far as 
possible. 
 
The caps filled with excised tissue were kept on 0.5 ml microcentrifuge tubes (Eppendorf® Safe-Lock 
Tubes) and put on ice until the whole procedure was finished. 
 
 
Figure 1: Example of Cresyl violet stained sections of tumour tissue at 2x magnification, right: SM6025LL (Case 3, 
Control), left: SM6077LL (Case 5, XRCC1 KO) 
 
 
Figure 2: Example of Cresyl violet stained sections of unaffected skin at 2x magnification, right: SM6025LL (Case 8, 
Control), left: SM9172RR (Case 15, XRCC1 KO) 
 
5.1.2 mRNA isolation 
5.1.2.1 Extraction 
mRNA extraction was done immediately after microdissection using the RNeasy® Mini Kit by 
QIAGEN according to the manufacturer’s protocol “Purification of Total RNA from Animal Cells using 
Spin Technology” in the RNeasy® Mini Handbook with the following adjustments. To transfer the 
tissue from the caps into tubes, the thermoplastic film containing the collected tissue was peeled off the 
cap with a sterile blade and put in a 1.5 ml microcentrifuge tube (Eppendorf® Safe-Lock Tubes) with 
110 µl of Buffer RLT.  
Material and Methods The effect of persistent DNA damage on cancer-associated stroma 
Page 14 University of Zurich, Institute of Veterinary Pharmacology and Toxicology, Vetsuisse Faculty Zürich, 25.01.2019 
Initially, different tissue homogenisation procedures were tested for their performance: either through 
varying durations of sonication with either Covaris® E220 Focused-ultrasonicator (Table 5) or 
Bioruptor® plus (Table 6), or just vortexing the tube without sonication. Vortexing proved to be the 
simplest and best protocol. Therefore, in all the following experiments tissue homogenisation was done 
by vortexing the tube repeatedly during 5 minutes and keeping it on ice in between. After 5 minutes, 
110 µl of 70% ethanol was added and the protocol was further followed from step 5 onwards, including 
the on-column DNase digestion. At the end, RNA was eluted in 30 µl RNase-free water and reloaded 
for a second elution step. Eluted RNA was aliquoted and immediately frozen and kept at -80°C. 
 
5.1.2.2 Quantification 
For one trial experiment, Thermo Scientific™ NanoDrop™ 2000/2000c Spectrophotometer was used 
according manufacturer’s instruction to quantify the mRNA yield (Table 6). 
For all the other experiments, quantification and quality control of the extracted mRNA was done by 
using 2200 Tape Station Software (Agilent Technologies) according to manufacturer’s instructions. 
 
5.1.3 Next-generation RNA sequencing 
10 ng of RNA diluted to a concentration of 0.33 ng/μl in a total volume of 30 μl was submitted for next-
generation RNA sequencing. The SMARTer Stranded Total RNA-seq Kit—Pico Input Mammalian 
(Clontech/ Takara Bio USA) was used according to manufacturer’s protocol for RNA library 
preparation and ribosomal RNA depletion. Single-read sequencing (125bp) was run using the Illumina 
HiSeq 4000 according to standard protocols of the Functional Genomics Centre Zurich (FGCZ). Quality 
control for the resulting NGS reads was performed with FastQC 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc). Trimmomatic [23] (v.0.36, 4 bases hard-
trimming from the start, and adapter trimming at the end) was used to trim the reads and STAR [24] 
(version 2.6.0c) was applied to align the trimmed reads with the reference genome and transcriptome 
(FASTA and GTF files, respectively, Ensembl, release89, CanFam3.1). Kallisto [25] (version 0.43.1) was 
used for gene expression quantification. For identification of differently expressed genes the 
R/Bioconductor package edgeR [26] (R version: 3.5.0, EdgeR version: 3.22.1) with the implemented 
count based negative binominal model was applied using the normalisation factor calculated by the 
trimmed mean of M values (TMM) method [27]. 
 
Analysis of RNA sequencing data 
Unsupervised hierarchical clustering (p ≤ 0.01, log2 ratio threshold of 0.5) was conducted for both, 
comparison of tumour stroma from Con and KO animals, and normal stroma from Con and KO 
animals. Gene ontology (GO) enrichment analysis was performed using goseq R Bioconductor package 
[28]. 
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Figure 3: Overview of workflow from tissue proceeding till analysis 
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5.2 Analysis of TIG-1 fibroblasts cultured in different FCS conditions 
5.2.1 Cell culture 
TIG-1 primary human fibroblasts were purchased from Coriell and cultured under standard conditions 
(37°C, 5% CO2) in Gibco™ DMEM, low glucose, GlutaMAX™ Supplement, pyruvate containing 15% 
fetal calf serum (FCS). 
 
5.2.2 Transfection 
At day one, four 10cm diameter dishes with 800’000 cells each were seeded. For siRNA delivery 
LipofectamineTM RNAiMAX Transfection Reagent (Invitrogen) was used, according to the 
manufacturer’s protocol. Part of the experiments were performed with two different sequences of 
XRCC1 siRNA to exclude off-target effects. For ATF4 two siRNA sequences were used in combination 
to achieve an appropriate level of knockdown. As a control, an unspecific siRNA sequence that does 
not target any gene product was used to mimic the transfection. 
Transfection was performed the day after seeding. 
 
siRNA Sequence Manufacturer Reference 
siControl Manufacturer’s proprietary information Eurogentec Eurogentec 
siXRCC1-1 5'-AGGGAAGAGGAAGUUGGAU-3' Eurogentec [29]  
siXRCC1-2 5'-GCUUGAGUUUUGUACGGUU-3' Eurogentec [10]  
siATF4-1 5'-GCCUAGGUCUCUUAGAUGA-3' Eurogentec [10] 
siATF4-2 5'-CUGCUUACGUUGCCAUGAU-3' Eurogentec [10] 
Table 2: siRNA used for transfection 
 
5.2.3 Splitting of cells 
24 hours after transfection, each of the transfected dishes was washed and trypsinised with 1 ml 1 x 
Trypsin solution. Trypsin was neutralised through addition of 2 ml of DMEM containing 5% FCS, and 
3 ml of the solution was distributed into 3 fresh 10 cm dishes with 10 ml of medium containing different 
concentrations of FCS to achieve final FCS concentrations of 15%, 5% and 1%, respectively, and 
incubated another 48 hours until analysis (Figure 4). 
 
5.2.4 Pictures of live cells 
Three days after transfection, dishes were photographed with a phase-contrast microscope at 10x 
magnification, right before collecting the cells.  
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5.2.5 Collection of cells 
The cells were collected 72h after transfection after washing once with cold 1 x PBS by scraping them 
off the petri dish in cold PBS. Cells were pelleted through centrifugation at 454 rcf at 4°C, and the pellets 
were stored in -80°C until further analysis. 
 
Figure 4:  Scheme of general experimental setup to investigate the expression of CAF markers in TIG-1 fibroblasts grown 
in medium containing different concentrations of FCS. 
 
5.2.6 Cell cycle analysis by flow cytometry 
For cell cycle analysis by FACS, trypsinised cells were fixed in ice-cold 70% ethanol for at least 30 min. 
To remove the fixation solution, cells were spun 5 min @ 250 rcf @4°C, and the supernatant was 
discarded. Cells were then resuspended in phosphate buffered saline with 100 g/ml of DNase free 
RNase A (Sigma) and incubated @37°C for 30 min, and further stained with 10 g/ml propidium iodide 
(Sigma). Samples were run on a FACScan (BD Biosciences) and the cell cycle distribution analysed 
using Modfit LT software (Verity Software House).  
 
5.2.7 mRNA isolation 
5.2.7.1 Extraction 
RNA extraction was performed using the RNeasy® Mini Kit by QIAGEN according to the 
manufacturer’s protocol “Purification of Total RNA from Animal Cells using Spin Technology” in the 
RNeasy® Mini Handbook, starting with 350 µl of RLT buffer. Homogenisation was done as described 
in step 3c. To elute the RNA 30 µl of RNase-free water was used. 
 
5.2.7.2 Quantification 
Thermo Scientific™ NanoDrop™ 2000/2000c Spectrophotometer was used according manufacturer’s 
instruction to quantify the extracted mRNA. 
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5.2.8 Reverse transcription 
RNA was reverse transcribed using the BioRad iScript™ cDNA Synthesis Kit according to 
manufacturer’s protocol with the LabCycler (SensoQuest), starting with 1000 ng RNA in 20 µl. The final 
product was diluted 1:5 in 80 µl dH2O and stored @ -80°C. 
 
5.2.9 RT-qPCR 
Quantitative real-time PCR (RT-qPCR) was done using the KAPA SYBR® FAST One-Step RT-qPCR 
Kit. 2 µl of each cDNA in a total volume of 10 µl was used and each sample run in duplicates on the 
CFX384 Touch™ Real-Time PCR detection system (BioRad). B2M and GAPDH were used as 
housekeeping genes. For quantification of gene expression, the comparative CT method was used, and 
results were expressed as fold change in mRNA levels. Primers used for RT-qPCR are detailed in Table 
3. 
 
Gene target Sequence Reference 
XRCC1 Fw: 5’-AACACGGACAGTGAGGAACA-3’ 
Rw: 5’-GCTGTGACGTATCGGATGAG-3’ 
[10] 
ATF4 Fw: 5’-GGGACAGATTGGATGTTGGAGA -3’ 
Rw: 5’-ACCCAACAGGGCATCCAAGT-3’ 
[10] 
ACTA2 Fw: 5’-TCAATGTCCCAGCCATGTAT-3’ 
Rw: 5’-CAGCACGATGCCAGTTGT-3’ 
[30] 
 
PALLD Fw: 5’-AACCGAGCAGGACAGAAC-3’ 
Rw: 5’-TGGTGGCACTCCCAATAC-3’ 
[14] 
FAP Fw: 5’-TCAGTGTGAGTGCTCTCATTGTAT-3’ 
Rw: 5’-GCTGTGCTTGCCTTATTGGT-3’ 
[14] 
PSAT1 Fw: 5’-CGGTCCTGGAATACAAGGTG-3’ 
Rw: 5’-AACCAAGCCCATGACGTAGA-3’ 
[10] 
SPARC Fw: 5’-GAAAGAAGATCCAGGCCCTC-3’ 
Rw: 5’-CTTCAGACTGCCCGGAGA-3’ 
[14] 
B2M Fw: 5’-ATGTCTCGCTCCGTGGCCTTA-3’ 
Rw: 5’-ATCTTGGGCTGTGACAAAGTC -3’ 
[14] 
GAPDH Fw: 5’-AGCCACATCGCTCAGACAC-3’ 
Rw: 5’-GCCCAATACGACCAAATCC-3’ 
[10] 
Table 3: List of primers used for RT-qPCR 
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5.2.10 Western blot 
5.2.10.1 Protein extraction 
For Western blot, whole cell extracts were prepared from collected TIG-1 pellets. For lysis, pellets were 
resuspended in M-PER™ Mammalian Protein Extraction Reagent supplemented with the cOmplete™, 
Mini, EDTA-free Protease Inhibitor Cocktail (Roche). The solution was kept for 30 minutes on a rotator 
wheel at 4°C. After the 30 minutes, the lysate was sonicated with Bioruptor® plus at 4°C, using three 
cycles with 30 seconds of sonication followed by a pause of 30 seconds each. At the end, the samples 
where centrifuged for 20 minutes at 4°C at 16049 rcf and the supernatant was transferred to a new 1.5ml 
tube (Eppendorf® Safe-Lock Tubes) and stored in -80°C. 
 
5.2.10.2 Quantification of total protein content 
Quantification of total protein was done using the Bradford assay right before loading the gel according 
to the manufacturer’s specifications. All samples were measured in duplicates. 
 
5.2.10.3 Gel preparation and Western blot 
Protein samples were run on the NovexTM WedgeWellTM 4-20% Tris-Glycine Gel (Invitrogen by 
Thermo Fisher Scientific) with 15-wells. 20 µg of protein in a total volume of 35µl were prepared per 
sample, containing 7 µl of leammli loading buffer (5x) and run with PowerEase® 500 (life technologies 
TM) for 1 hour 30 minutes at 125V. 
Transfer of proteins onto Immobilon PVDF FL membrane was performed using the novex® XCell II 
TM Blot Module (life technologies TM) for 2 hours at 25V.  
After incubation with the primary and secondary antibodies (see Table 4), respectively, the membrane 
was scanned with Odyssey® CLx. Image StudioTM was used to analyse and quantify protein bands. 
 
5.2.10.4 Antibodies for Western blot 
Antibody Manufacturer, order no. Isotype 
Palladin Novus Biologicals, NBP1-25959 Mouse monoclonal 
PSAT1 Novus Biologicals, 21020002 Rabbit polyclonal 
αSMA Dako Cytomation, M0851 Mouse monoclonal 
GAPDH Abcam, ab9484 Mouse monoclonal 
Tubulin Sigma, T5168 Mouse monoclonal 
Table 4: List of antibodies used for Western blot 
 
5.3 Statistical analysis and representation of results 
GraphPad Prism was used for statistical analysis and visual representation of the collected RT-qPCR 
and Western blot data. 
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6 Results 
6.1 Analysing the impact of XRCC1 depletion in TIG-1 fibroblasts under 
nutrient-restricted conditions 
6.1.1 XRCC1 KD imparts TIG-1 cells with a growth and/or survival advantage 
under low-serum conditions 
Yet unpublished results from metabolomics analyses of control and XRCC1 KD TIG-1 human primary 
fibroblasts suggested a depletion in BER capacity to induce a metabolic rewiring that promotes 
nutritional self-sufficiency of these cells. To investigate whether this XRCC1 KD-mediated metabolic 
rewiring could indeed result in better growth of TIG-1 cells under nutrient-restricted conditions, we 
exposed cells to culture medium containing different amounts of fetal calf serum (FCS) after siRNA 
treatment, and analysed cell morphology and density 72h after KD using images taken with a phase-
contrast microscope (see Figure 4 for a scheme of the experiment). The respective KDs were validated 
by RT-qPCR (Figure 7). When cells were grown in medium containing 5% FCS, no clear differences in 
cell number or morphology could be observed between XRCC1 KD cells and control cells (Figure 5A 
and B). Interestingly however, when the FCS concentration was lowered to 1%, XRCC1 KD cells clearly 
displayed a vastly increased cell number, a more elongated fibroblast-like cell morphology and less 
rounded and floating cells compared to controls (Figure 6). These results were confirmed in several 
independent repetitions of the experiment (n = 4), and were also validated with a second siRNA 
sequence against XRCC1 (data not shown).  
Taken together, our results strongly support the hypothesis that XRCC1 KD confers the cells with a 
selective survival and/or growth advantage in nutrient-limited conditions. 
 
6.1.2 The XRCC1 KD-induced growth and/or survival advantage of TIG-1 cells in 
low-serum conditions is mediated by ATF4 
Since XRCC1 KD has been shown to induce the transcription factor ATF4 in TIG-1 cells, which can 
induce metabolic adaptations to stressful conditions [10, 31], and our metabolomics analyses indicated 
the metabolic rewiring after XRCC1 KD to be largely dependent on ATF4 (unpublished observations), 
we wanted to investigate whether the increased growth and/or survival of TIG-1 cells upon XRCC1 KD 
in low FCS conditions were due to ATF4. Knocking down ATF4 alone or in combination with XRCC1 
showed a slight decrease in cell numbers and slightly more floating cells at 5% FCS compared to control 
cells, suggesting that a baseline ATF4 level is required for optimal fitness of TIG-1 cells (Figure 5C and 
D). Strikingly, when cultured at 1% FCS, a combined KD of ATF4 and XRCC1 completely rescued the 
phenotype observed with XRCC1 KD alone, and was virtually indistinguishable from control cells 
(Figure 6D).  
To verify that the different growth conditions did not alter KD efficiency, we analysed expression of 
XRCC1, ATF4 and several of their respective downstream targets by RT-qPCR in cells grown in 15%, 
5%, or 1% FCS (Figure 7). KD efficiencies for XRCC1 and ATF4 were comparable in all three conditions. 
The effectiveness of ATF4 KD was further demonstrated by the strong decrease in expression of PSAT1, 
a direct downstream target of ATF4, either with ATF4 KD alone or in combination with XRCC1 KD. As 
reported previously [10, 14], XRCC1 KD resulted in inductions of PSAT1, ACTA2, PALLD, FAP and 
SPARC (Figure 7), which was also confirmed with an independent siRNA against XRCC1 (Figure 8). 
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Expression of PSAT1, ACTA2, and PALLD, but not of FAP and SPARC, could be rescued upon co-KD 
of ATF4, as expected [10, 14]. Similarly, analysis of protein expression of PALLD, ACTA2 and PSAT1 
demonstrated the ATF4-dependent induction of these targets after XRCC1 KD at 5% and 1% FCS, 
respectively (Figure 9). Thus, varying FCS conditions did not cause differences in KD efficiency. 
Summarising, these findings suggest that the survival and/or growth advantage in TIG-1 cells imparted 
by XRCC1 KD at low serum concentrations depends on the transcription factor ATF4. 
 
6.1.3 The XRCC1 KD-mediated growth advantage of TIG-1 cells under low-serum 
conditions is not caused by increased proliferation, but likely due to an increased 
resistance to apoptosis 
The increased cell number of XRCC1 KD cells under low FCS conditions could in principle either be 
due to increased proliferation or decreased apoptosis, or a combination of both. To differentiate 
between the two scenarios, we analysed the cell cycle distribution of control and XRCC1 KD cells grown 
in 1%, 5%, and 15% FCS, respectively, using flow cytometry. As expected from previous findings [10], 
XRCC1 KD cells grown at 15% FCS displayed an increase in G1 cells, and a concomitant decrease in S-
phase cells, suggesting that XRCC1 KD under these conditions causes the cell cycle to slow down 
slightly by prolonging the G1-phase (Figure 10). Similarly to this, the cell cycle distribution at 5% still 
displayed more XRCC1 KD cells in G1 and slightly less in S-phase, compared to control cells. When 
analysing cells grown at 1% FCS, however, no significant differences in the percentage of cells in G1, S, 
or G2 cell cycle phases could be detected between control and XRCC1 KD cells. Indeed, the amount of 
control cells in G1 clearly increased and cells in S-phase decreased with lower FCS concentrations, 
while no FCS-dependent change of cell cycle distribution could be observed for XRCC1 KD cells. These 
findings show that XRCC1 KD do not have a proliferative advantage over control cells at low FCS 
conditions. Therefore, it is highly likely that the difference in cell density at low FCS concentrations is 
due to a lower rate of apoptosis in XRCC1 KD cells compared to control cells. This hypothesis is 
supported by the phenotype of control cells grown at 1% FCS that show an increase in rounded, 
detaching cells (Figure 6A).  
In conclusion, our analyses clearly demonstrate that a KD of XRCC1 in TIG-1 cells induces a survival 
advantage under serum-restricted growth conditions that depends on the transcription factor ATF4, 
presumably through rendering cells more resistant to apoptosis. 
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Figure 5: No difference in growth of control vs XRCC1 KD TIG-1 at 5% FCS. Phase-contrast images of TIG-1 human 
fibroblasts from one representative experiment taken on the third day upon transfection with siRNAs as indicated, started 
with the same number of cells in each condition and split to DMEM medium containing 5% of FCS 24 h after transfection. 
Four different fields randomly chosen on each plate are shown per condition. 
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Figure 6: Selective growth and/or survival advantage of XRCC1 KD TIG-1 cells at 1% FCS. Phase-contrast images of 
TIG-1 human fibroblasts from one representative experiment taken on the third day upon transfection with siRNA as 
indicated, started with the same number of cells in each condition and split to DMEM medium containing 1% of FCS 24 
h after transfection. Four different fields randomly chosen on each plate are shown per condition. 
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Figure 7: Validation of siRNA-mediated KD of XRCC1 and ATF4 in TIG-1 human fibroblasts grown in different FCS 
conditions. mRNA levels of indicated genes in TIG-1 fibroblasts transfected with either a non-targeting control siRNA 
(siCtrl), or siRNAs targeting XRCC1, ATF4, or both grown in different FCS conditions were analysed by RT-qPCR and 
normalised to GAPDH and B2M and with the respective control treatment set to 1. Data are presented as mean SEM.  
n = 2 for 15%, and n = 4 for 5% and 1%, respectively. 
 
 
Figure 8: Validation of siXRCC1-mediated transcriptional changes with a second siRNA sequence against XRCC1. 
mRNA levels of indicated genes in TIG-1 fibroblasts transfected with either a non-targeting control siRNA or siRNA 
XRCC1-2, grown in 15% FCS were analysed by RT-qPCR and normalised to GAPDH and B2M and with the control 
treatment set to 1. Data are presented as mean SEM. n = 5. 
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Figure 9: Validation of XRCC1 KD-mediated ATF4-dependent protein expression changes by Western blot analysis 
of TIG-1 grown under different FCS conditions. A) Western blot analysis of Palladin, aSMA and PSAT1. GAPDH or 
Tubulin served as loading control. B) Quantification of protein levels as seen in A). Values are mean ± SD from 2 
independent experiments for 5% and 1 experiment for 1%, normalised to the loading control, with the control of the 
respective condition set to 1.  
 
 
Figure 10: XRCC1 KD cells do not proliferate more than control cells under low FCS conditions. Cell-cycle 
distribution analysis by flow cytometry of control and XRCC1 KD TIG-1 cells. Shown is the percentage of cells in the 
respective cell cycle phases. Data are mean SD of 2 independent experiments. 
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6.2 Identification of gene-expression changes in cancer-associated stroma 
from control and conditional XRCC1 KO mice 
6.2.1 Establishment of tissue homogenisation process for mRNA isolation 
To identify the best procedure to homogenise fresh-frozen tissue prior to mRNA isolation, four 10 m 
sections of the same fresh frozen mouse skin sample mounted on conventional glass slides were used. 
The sections were scraped off the slides as whole and put in 1.5 ml microcentrifuge tubes (Eppendorf® 
Safe-Lock Tubes). Then tissue homogenisation was performed using either three different durations of 
sonication with Covaris® E220 Focused-ultrasonicator, or no sonication but just vortexing for tissue 
homogenisation, respectively (Table 5). The extracted mRNA was then analysed to obtain RINe values 
as well as concentration of the samples (Table 5). Procedure D1 (no sonication, repeated vortexing) 
showed the best RINe value and an appropriate concentration of mRNA (Table 5). As it was also the 
easiest method without need of any special equipment, D1 was considered the best method for tissue 
homogenisation for this purpose. 
 
Condition Homogenisation treatment RINe Concentration [pg/µl] 
A1 1 min sonication (Covaris® E220 Focused-ultrasonicator) 2.4 26500 
B1 3 min sonication (Covaris® E220 Focused-ultrasonicator) 1.9 5990 
C1 5 min sonication (Covaris® E220 Focused-ultrasonicator) 1.7 11500 
D1 Repeated vortexing for 5 min 2.5 10800 
Table 5: Tissue homogenisation techniques tested for RNA isolation from fresh-frozen tissue with respective RINe 
values and RNA yields. 
 
To verify this result and test an additional way of sonication, a second trial was performed with three 
more sections of the same mouse skin tissue comparing sonication using the Bioruptor® plus with 
vortexing only. Again, vortexing the sample proved to be the simplest method and also yielded the 
highest amount of mRNA (Table 6). Thus, for further experiments, the vortexing protocol was used for 
tissue homogenisation. 
 
Condition Homogenisation treatment Concentration [pg/µl] 
S 1 1 min of sonication (Bioruptor® plus) 4.5 ng/µl 
S 2 3 cycles of sonication (3 x 30 sec on, 30 sec off) (Bioruptor® plus) 5.5 ng/µl 
S 3 Vortexing repeatedly for 5 min 5.9 ng/µl 
Table 6: List of samples and mRNA yield after mRNA isolation trial using Bioruptor® plus or vortexing 
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6.2.2 Isolation of tumour-associated and normal stroma from mouse samples 
Selective isolation of CAS from control and KO animals (sample number 1 to 7 listed in Table 7) was 
performed by LCM. The suitable areas were chosen with advice from a pathologist. In general, not 
much stroma could be found inside the tumour, so stroma from the borders was taken (e.g. Figure 11 
A). If available, also stroma from within the tumour was taken (Figure 11 B and C). Normal stroma 
from unaffected skin was isolated from Samples 8 to 15 listed in Table 7 using LCM (See Figure 12 for 
examples of selective isolation). To validate the isolation of the chosen tissue parts, the CapSure® Cap 
and the processed tissue were checked after excision, and pictures were taken to track progress during 
the entire procedure (examples in Figure 11 and Figure 12). RNA was isolated from CAS and normal 
stroma from all these cases, and the RINe values and quantity determined (Table 7).  
  
Sample # Mouse ID Categorisation Sample type RINe Concentration 
[pg/ul] 
1 SM6026RR Control Primary tumour 4.8 638 
2 SM6030L Control Primary tumour 5.7 959 
3 SM6025LL Control Primary tumour - 471 
4 SM6029R Control Primary tumour - 736 
5 SM6077L KO Primary tumour 4.9 592 
6 SM6067LR KO Primary tumour 3.9 2380 
7 SM4962L KO Primary tumour - 598 
8 SM6025LL Control Skin 4.2 585 
9 SM6030L Control Skin 5.3 643 
10 SM6027LR Control Skin 3.7 675 
11 SM9173R Control Skin 8.5 475 
12 SM6077L KO Skin 4.9 741 
13 SM6067LR KO Skin 2.8 681 
14 SM9840R KO Skin 3.9 1020 
15 SM9172RR KO Skin - 104 
Table 7: Sample description of the selected tissue for analysis, and concentration and quality of isolated mRNA.  
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Figure 11: Visual validation of the excised cancer-associated stroma with Laser-capture microdissection from mouse 
primary tumours at 10x magnification. a) native tissue b) excised stroma on the CapSure® Cap c) tissue after 
microdissection. A) SM6030L (Case 2) B) & C) SM6077L (Case 5) 
 
 
Figure 12: Visual validation of the excised normal stroma with laser-capture microdissection from mouse skin at 2x 
magnification. a) native tissue b) excised stroma on the CapSure® Cap c) tissue after microdissection. A) SM8940R 
(Case 14) B) & C) SM9172RR (Case 15) 
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6.2.3 Analysis of gene expression in cancer-associated and normal stroma from 
control and KO animals 
To identify gene expression changes between CAS and normal stroma isolated from control and XRCC1 
KO mice, the extracted RNA was analysed by NGS. Unsupervised hierarchical clustering of all samples 
was performed to compare the gene expression in CAS from control and KO animals (Figure 13), as 
well as in normal skin from control and KO mice (Figure 16). Several samples were excluded due to 
insufficient performance in NGS. 
The main focus of this investigation was laid on identifying differences in gene expression in CAS 
between KO and control animals. With a significance threshold of p  0.01 and log2 fold change 
threshold of  0.5, comparing CAS from KO over CAS from control animal, 473 differently expressed 
genes were identified. Of these, 77 genes were up-regulated and 396 down-regulated in CAS of KO 
animals. Gene ontology analysis of the deregulated genes identified six clusters (as indicated by the 
colours on the Y-axis in Figure 13). The biological processes identified within these clusters were the 
following: the green cluster (cluster 1) contained genes involved in cell adhesion; the yellow cluster 
(cluster 2), the light blue cluster (cluster 3) and the blue cluster (cluster 4) genes involved in peptide 
cross-linking and epidermis development; the orange cluster (cluster 5) contained as well genes 
involved in skin development and genes involved in steroid biosynthetic process; the red cluster 
(cluster 6) displayed genes involved in steroid hormone mediated signaling pathway (Figure 14). Gene 
ontology enrichment data for Molecular Functions identified the following main categories (Figure 15): 
cluster 1 contained genes involved in integrin binding; genes involved in structural molecule activity 
were found in cluster 2, 3 and 4; in addition, cluster 2 contained genes involved in structural constituent 
of epidermis, transition metal ion binding, calcium ion binding and cell adhesion molecule binding; 
genes corresponding to structural constituent of cytoskeleton were found in cluster 3 and 4. For Cellular 
Compartments the following main categories were identified: in cluster 1 genes assigned to 
extracellular region, extracellular space, extracellular matrix and collagen trimer were found; cluster 2, 
3 and 4 contained genes out of the category cornified envelope; other categories identified for cluster 2 
were extracellular exosome, cell junction, intermediate filament cytoskeleton, intermediate filament 
and keratin filament; additional, in cluster 4 genes corresponding brush border membrane were found 
(Figure 15). For a more detailed insight, the top 50 up-and down-regulated genes and their association 
with the respective GO clusters are listed in Table 8 (genes up-regulated in XRCC1 KO CAS) and Table 
9 (genes down-regulated in XRCC1 KO CAS).  
Taken together, NGS analysis revealed clear differences in CAS and normal stroma from XRCC1-KO 
compared to control mice. Preliminary analyses suggest that observed changes are consistent with 
changes in stromal cell biology. A more thorough analysis of these data has the potential to reveal the 
mechanisms underlying the observed increase of tumour growth and metastasis brought about by a 
stromal deletion of XRCC1.  
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Figure 13: Hierarchical clustering and heatmap of CAS isolated from control and KO mice analysed by NGS (p ≤ 0.01, 
log2 ratio threshold of 0.5). 3 samples of CAS from control animals on the left side, and the two samples from KO animals 
cluster, respectively. Each row features one gene, and each column represents one sample. Gene expression is indicated 
by the Color Key, red for a relative up-regulation, blue for a relative down-regulation. The bars on the left Y-axis indicate 
GO clusters associated with the expression patterns. 
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Figure 14: Biological Processes identified through gene ontology enrichment for each cluster. Term = affected biological 
process, ID = Gene ontology accession number, p = p-value indicating the significance of overlap between biological 
process and the cancer associated stroma. 
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Figure 15: Molecular Functions (left) and Cellular Compartments (right) identified through gene ontology enrichment 
for the displayed clusters. Term = affected biological process, ID = Gene ontology accession number, p = p-value indicating 
the significance of overlap between biological process and the cancer associated stroma.  
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Gene Name log2 Ratio pValue C 1 C 2 C 3 C 4 C 5 C 6 
AC174678.2 6.07 7.98e-7       
Sfrp5 5.99 0.0000148 x      
Lats2 5.31 0.000767       
Gbp2b 4.99 0.0002       
Gm28539 4.68 0.000392       
Thbs4 4.53 0.0000109 x x     
Shh 4.48 0.00365 x x   x  
Gdf10 4.21 0.00157 x      
Gm38284 4.16 0.00911       
Gm20547 4.07 0.0041 x      
Gm43738 4.07 0.00773       
Nov 4.04 3.36e-7 x      
Bcl2a1a 3.99 0.00882       
Col8a1 3.96 0.00000409 x      
C1ql3 3.95 0.0061 x      
AC154482.1 3.91 0.00458       
Adamts18 3.72 0.00474       
A630073D07Rik 3.65 0.00769       
Myh3 3.65 0.0108       
Cemip 3.58 0.00000878 x      
Col28a1 2.96 0.00563 x      
Disp2 2.93 0.01       
Piezo2 2.9 0.000416       
Prkg2 2.8 0.000185       
Cpxm2 2.7 0.00000972 x      
Cxcl9 2.67 0.00426 x      
Entpd3 2.53 0.009 x      
Mgp 2.49 0.00214 x x     
Mpz 2.28 0.00444       
Mfap5 2.27 0.00256 x      
Col11a1 2.15 0.00627 x      
Nr2f2 2.14 0.000565      x 
C1qtnf3 2.14 0.00314 x      
Arhgap22 2.07 0.000846       
Ccl21a 2.05 0.0106       
Gpc3 2.02 0.0061 x      
Adamtsl3 2.01 0.00473 x      
Col14a1 1.93 0.00644 x      
Lrrc17 1.92 0.00391 x      
Vcam1 1.89 0.00532 x x     
Ogn 1.85 0.0017 x      
Cxxc5 1.83 0.0109       
Hist1h3i 1.8 0.00832       
Pde7b 1.76 0.00409       
Cybb 1.71 0.000994       
Ptprb 1.7 0.00309       
Apod 1.68 0.00697 x      
Cp 1.62 0.00283 x      
C2 1.61 0.00561 x      
Tnfaip2 1.6 0.00038       
Table 8: List of top 50 up-regulated genes in CAS from XRCC1 KO mice found by NGS. The association of the genes 
with the 6 identified GO clusters, represented by the coloured columns, is indicated with an x in the respective column. 
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Gene Name log2 Ratio pValue C 1 C 2 C 3 C 4 C 5 C 6 
Lor -10.00 3.28e-10  x x x   
Flg -10.00 8.33e-8  x x x   
Hrnr -9.63 2.43e-9  x x x   
Krt1 -9.32 2.87e-7 x x x x   
Krt77 -8.99 3.93e-8  x x x   
Calm4 -8.83 1.26e-9  x     
Flg2 -8.32 6.2e-8  x     
Fam25c -7.96 4.5e-10       
Dsc1 -7.84 6.32e-11 x x     
Krt10 -7.46 5.61e-7 x x x x   
Kprp -7.45 2.62e-9       
Krt6b -7.45 0.00244  x x x   
2310046K23Rik -7.42 0.00000337  x x x   
2310050C09Rik -7.31 2.91e-9       
Nccrp1 -7.11 9.31e-9 x      
Krtdap -7.08 1.84e-9 x      
Dsg1a -6.96 9.63e-7 x x     
Ivl -6.91 2.86e-8  x x x   
Lce1e -6.77 0.00000514  x x x   
Lce1m -6.72 3.17e-8  x x x   
Lce1f -6.69 0.0000166  x x x   
Lce1h -6.63 0.00  x x x   
Krt16 -6.6 0.00175  x x x   
Lce1c -6.58 6.86e-7  x x x   
Lce1i -6.57 0.00000158  x x x   
Lce1j -6.50 0.0000178  x x x   
Cgn -6.48 2.07e-8       
Krt78 -6.44 4.12e-7 x x x x   
Sprr1b -6.43 0.00000638  x x x   
Lce1g -6.33 0.0000686  x x x   
Sprr2a2 -6.30 0.000121  x x x   
Rptn -6.28 0.00000188 x x x x   
Il1f5 -6.27 1.54e-7 x      
Cnfn -6.21 3.86e-7  x x x   
Lce1d -6.19 0.00000287  x x x   
Pla2g4f -6.10 7.97e-7  x     
Pla2g2f -6.09 0.00000155 x      
Ly6d -6.07 2.1e-7       
Lce1a1 -6.05 0.00000378  x x x   
Sprr2a1 -6.05 0.000816  x x x   
Ppfia3 -6.01 4.42e-7       
Mapk13 -5.91 0.00000119       
Casp14 -5.9 7.06e-7 x      
Gsdma -5.77 0.0000132       
Cdcp1 -5.73 0.00000322       
Exph5 -5.72 0.00000592       
Fgfbp1 -5.70 0.0000129 x      
Lce1a2 -5.68 0.00000492  x x x   
Angptl7 -5.68 0.0000873 x      
BC100530 -5.65 0.000986       
Table 9: List of top 50 down-regulated genes in CAS from XRCC1 KO mice found by NGS. The association of the genes 
with the 6 identified GO clusters, represented by the coloured columns, is indicated with an x in the respective column. 
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Figure 16: Hierarchical clustering and heatmap of normal stroma isolated from control and KO mice analysed by NGS (p 
≤ 0.01, log2 ratio threshold of 0.5). The 3 samples of normal stroma isolated from control animals, and the 3 samples of 
normal stroma from KO animals cluster, respectively. Each row features one gene, and each column represents one 
sample. Gene expression is indicated by the Color Key, red for a relative up-regulation, blue for a relative down-
regulation. The bars on the left side indicate clusters associated with the respective expression patterns (legend on the 
right side). 
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Table 10: List of top 20 up-regulated (left) and down-regulated (right) genes found by RNA sequencing comparing 
normal, unaffected skin from XRCC1 KO and control mice. 
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7 Discussion 
Nowadays, cancer plays a huge role in our health care system. Globally, about 1 in 6 deaths occurs due 
to cancer (https://www.who.int/en/news-room/fact-sheets/detail/cancer), despite ongoing research for 
novel ways of diagnosis and therapy. Recent findings have shown, that cancer cells do not manifest the 
disease alone but strongly depend on their surrounding stroma, the CAS. Thus, targeting CAS is 
regarded as a promising approach for the development of new cancer treatments [4, 5]. One prominent 
component within CAS are the CAFs, which have been shown to support tumour growth and 
metastasis, and are a major factor in determining the tumour outcome [7]. 
It is already known, that CAF formation can be induced in vitro by inflammatory cytokines, such as 
TGF β and/or ROS [8, 9], but the molecular mechanisms underlying this transformation remains 
unclear. Our group has recently demonstrated that exposure to these agents results in a depletion of 
XRCC1, which causes persistent DNA damage, that in turn leads to activation of CAFs that support 
growth and motility of tumour cells in vitro. This reprogramming, which can also be observed upon 
XRCC1 KD in fibroblasts, partly depends on the integrative stress response through upregulation of 
ATF4 which seems to induce a metabolic rewiring that might increase nutritional self-sufficiency ([10, 
14] and unpublished data). But the reason for this reprogramming through XRCC1 downregulation 
remains enigmatic. The available data led us to hypothesise that XRCC1 KD cells might survive better 
in a ‘nutrient-starved’ environment. By analysing TIG-1 fibroblasts grown under nutrient-restricted 
conditions, we found that XRCC1 KD cells, which show a CAF-like phenotype, truly have a growth 
and/or survival advantage over control cells. Additionally, by knocking down ATF4 together with 
XRCC1, we demonstrated that this advantage depends on ATF4 (Figure 6). An analysis of the cell cycle 
revealed that XRCC1 KD cells did not proliferate more than control cells, suggesting that their 
advantage at nutrient-starved conditions is likely due to an increased resistance to apoptosis (Figure 
10). 
Furthermore, data from our lab demonstrated that a stromal XRCC1 knockout (KO) triggers increased 
tumour growth and metastasis in vivo (unpublished data). To understand what molecular changes in 
the stroma of XRCC1 KO mice could be the underlying cause for this phenotype, we analysed the 
molecular changes in CAS from control and XRCC1 KO mice by laser-capture microdissection coupled 
with NGS. By doing so, we found differences in gene expression between the two groups, which 
presumably are connected to the increased tumour growth and metastasis and will allow further, more 
detailed analysis (Figure 13, Figure 14, Figure 15). 
 
7.1 Identification of an ATF4-dependent survival advantage of XRCC1 KD 
cells under low-serum condition 
By seeding the same number of TIG-1 fibroblasts, transfected with either siXRCC1 or a control siRNA, 
grow in medium containing different concentrations of FCS (15%, 5% or 1%), we were able to show 
that, with a decreasing amount of serum, the XRCC1 KD cells showed increased density and less 
rounded, floating cells compared to the control cells (Figure 6). This demonstrated that XRCC1 KD cells 
are more viable under starved conditions. To verify that the KD capacity of the siRNAs was not affected 
by the low-FCS condition, RT-qPCR and Western blot were performed, analysing the direct target of 
the siRNA and also several respective downstream targets. However, to get the samples for this 
validation was quite challenging. We were facing the problem, that in the 1% FCS condition the number 
of control, siATF4 and combined siATF4 and XRCC1 KD cells all were considerably lower than the 
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number of XRCC1 KD cells on the day of cell collection, making it difficult to extract sufficient mRNA 
or protein for downstream analysis. To improve the cell numbers, we tried to start with more cells, by 
seeding more cells for the siRNA treatment, and subsequently splitting 2/3 of these cells into the 1% 
FCS condition. However, contrary to expectations, this approach failed and even aggravated the 
outcome. Most of the control cells were detached and floating, while XRCC1 KD cells were still 
perfectly viable and formed a dense cell layer. This led us to the conclusion, that with a higher number 
of cells the already sparse FCS was used up even faster, and thus all except XRCC1 KD cells were 
starving to death. This result further supported the hypothesis that XRCC1-depleted TIG-1 fibroblasts 
have an advantage in nutrient-restricted conditions due to an ATF4 mediated metabolic 
reprogramming which in turn seem to support nutritional self-sufficiency (unpublished observations).  
The finding that a decline in BER capacity confers fibroblasts with an increased resilience towards 
nutrient starvation is very interesting from several points of view. We have previously demonstrated 
that lengthened exposure to pro-inflammatory cytokines and ROS, both of which are widely accepted 
as inducers of CAF activation, induce a deficiency in BER through transcriptional down-regulation of 
XRCC1 and lead to persistent DNA damage, suggesting a link between XRCC1 downregulation and 
CAF activation [14]. Indeed, CAF activation can be achieved directly by XRCC1 KD without exposure 
to cytokines or ROS, suggesting that persistent DNA damage is an integral part of the CAF activation 
mechanism [14]. Mechanistically, persistent DNA damage signalling by ATM has been shown to 
phosphorylate the transcription factor Sp1, thus initiating its degradation [32]. As Sp1 in turn controls 
expression of XRCC1, degradation of Sp1 leads to a suppression of XRCC1 transcription, thus 
triggering a decline in BER capacity and further aggravating the persistent DNA damage. A very 
similar mechanism might be involved in reading to XRCC1 downregulation upon exposure to TGF β 
or ROS, and suggests BER downregulation in fibroblasts to be a general response to stressful events. 
But the question why the cell would initiate such a BER decline under stressful conditions has remained 
elusive until now. It has been suggested, that such cells might undergo apoptosis more easily or be 
eliminated better by the immune system [32]. However, human fibroblasts have been shown to be 
highly resistant to apoptosis, and undergo senescence much rather than inducing apoptosis, and can 
be maintained in culture for extremely long periods in that state [33]. This is in line with the crucial role 
of fibroblasts to maintain the organism’s structural integrity, because, even in a post-replicative 
senescent state, fibroblasts are still able to actively shape the extracellular matrix. This would not be 
possible were damaged fibroblasts quickly eliminated through apoptosis or by the immune system. 
Additionally, yet unpublished data from our lab reveals wide-ranging metabolic reprogramming of 
fibroblasts in which BER capacity is depleted by XRCC1 KD. These changes potentially increase cellular 
self-sufficiency with respect to many metabolites, such as nucleotides, amino acids and energy. Our 
finding showing that fibroblasts experiencing persistent DNA damage have a survival advantage 
under nutrient-starved conditions further support the functionality of this metabolic reprogramming. 
Thus, we propose that under stressful circumstances, such as protracted inflammation or persistent 
signalling from tumour cells, DNA damage is induced in the tissue-resident fibroblasts, which leads to 
ATM-signalling that in turn destabilizes the transcription factor Sp1. This causes XRCC1 transcription 
to decrease, resulting in a BER-depleted cellular state that further aggravates persistence of DNA 
damage. This initiates ATF4-dependent metabolic reprogramming that increases cellular self-
sufficiency in nutrients, thus enabling these cells to survive even in nutrient-starved conditions. 
Through this increased resilience, fibroblasts can still fulfil their important structural roles in the 
organism, as they are the main responsible for synthesis of the extracellular matrix, that provides the 
structural scaffold for other cells to grow on and mechanical properties that determine the integrity of 
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organs [34]. Such a resilience mechanism seems important especially also for CAFs. Per definitionem, 
CAFs are located closely adjacent to the epithelial tumour-forming, rapidly dividing cancer cells. These 
cancer cells have a huge demand in a wide variety of nutrients to sustain their high proliferative rate, 
and they have been shown to remodel the surrounding stroma in a way that increases the delivery of 
such nutrients and other growth-promoting molecules [5]. Specifically, CAFs have been found to take 
up metabolic waste of cancer cells to produce metabolites that in turn are secreted again to feed the 
tumour [18]. It is thus thought that most of the ‘rich’ nutrients are drained away from CAFs to support 
tumour growth, which results in the necessity for CAFs to survive in a ‘starved’ environment. The 
observed down-regulation of BER capacity in fibroblasts exposed to a maintained pro-inflammatory 
stimulation that induces CAF generation seems to thus increase self-sufficiency of these cells, which 
would be beneficial in a starved environment. In summary, our observations suggest the metabolic 
rewiring upon BER decline after stressful insults to be a physiological response of fibroblasts to ensure 
their survival in nutrient-starved conditions, in order to fulfil their principal role of maintaining the 
structure of the organism.  
ATF4 is a transcription factor that has a dual role in cells promoting either their adaptation to endure 
stress or the induction of apoptosis [35]. Furthermore, an indirect influence of ATF4 on cell viability 
modulating the balance of anabolic and catabolic processes has been suggested. ATF4 activates 
transcription of a set of targets involved in autophagy, but also targets that upregulate protein synthesis. 
This whole process is quite complex and bimodal, in a way that at the end it can have either pro- or 
anti-apoptotic effects, likely depending on the balance between anabolism and catabolism. This balance 
is also context-dependent, as for example autophagy can become damaging when the amount of 
expendable proteins is exhausted and the cell is not able to compensate for the loss. Thus, highly 
proliferative cells might be more resistant to autophagy, as they have high levels of protein synthesis 
and ER load. Moreover, it has been suggested that cancer cells might be more resistant to pro-apoptotic 
ATF4 targets, because they already have defects in apoptotic signalling downstream of ATF4 [35]. The 
ATF4-dependence of the metabolic reprogramming that we observed upon XRCC1 is nicely in line with 
our previous findings demonstrating ATF4 induction after XRCC1 KD [10] as well as its involvement 
in the transcription of several CAF-markers that are activated upon XRCC1 KD [14]. It also raises 
several more intriguing questions. Firstly, it will be of interest to determine which are the exact ATF4-
dependent changes that allow cells to thrive in nutrient-starved conditions. Thus far unpublished 
results from our lab show wide-ranging changes in metabolic processes involving synthesis of 
nucleotides and amino acids and the production of energy, some or all of which could be involved in 
this. Furthermore, our results suggest that rather than having a proliferative advantage, XRCC1 KD 
cells are more resistant to apoptosis in nutrient-starved conditions which confers them a survival 
advantage that results in higher cell density. Hence, XRCC1 KD cells seem somehow to be able to 
exploit ATF4, similarly to cancer cells, to reduce stress resulting from nutrient limitation and benefit 
from its pro-survival effects. The increased resistance of XRCC1 KD cells to apoptosis should further 
be verified by i) measuring amounts of apoptotic cells when grown at 1% FCS, ii) investigating the 
propensity to undergo apoptosis upon stimulation with known apoptosis-inducing agents, iii) analyse 
the activation status of ATF4-dependent apoptotic and pro-survival signalling pathways, iv) 
demonstrate by loss-of-function and gain-of-function experiments which signalling circuitries are 
mediating the observed resistance to apoptosis. A deeper understanding of these mechanisms might 
also facilitate the identification of pharmacological targets to target CAS, which is currently viewed as 
a promising strategy for cancer treatment [4, 36-40].  
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7.2 Identification of gene-expression changes in cancer-associated stroma 
from control and conditional XRCC1 KO mice 
7.2.1 Mouse model and sample preparation 
To analyse the impact of XRCC1 KO on tumour growth and metastasis in vivo, it was necessary to 
employ a conditional KO strategy, because a full KO of XRCC1 is embryonically lethal [15, 16]. With 
our model using the Col1a2-Cre approach, it was possible to restrict the KO largely to fibroblasts [41]. 
Additionally, the inducibility by Tamoxifen added another layer of control, making it possible to 
induce the KO after weaning by Tamoxifen administration, therefore circumventing possible 
developmental defects. Thus, we generated apparently healthy mice without any overt phenotypic 
differences between KO and control animals. The mouse model was already established in the 
Markkanen lab before my project started and the animals were in breeding. 
As tumour model to analyse the effect of the stroma on tumour growth and metastasis, Lewis Lung 
Carcinoma (LLC) cells were chosen for injection for several reasons. Since LLCs are often used in 
tumour research, they are well characterised, and primary tumours grow reliably [42]. Importantly, 
LLCs also show a certain tendency to metastasise, which was important to analyse the effect on 
metastasis. And finally, since our recipient animals were fully immune-competent, a syngeneic cell line 
had to be used. For all these reasons, LLCs were the cells of choice.  
During surgical tissue excision, fresh-freezing and sample preparation for LCM, we took great care to 
treat all the samples the same. Nevertheless, there were large variations in the extracted mRNA quality 
and quantity (Table 7). There are a lot of possible reasons that could explain these differences, ranging 
from differences in the exact time elapsed between surgical excision and freezing, the preparation of 
sections and slides, and others. The Institute for Veterinary Pathology Zürich made an effort to cut the 
samples as soon as possible, but even so they had busy days where the samples then stayed in the 
freezer at -20°C for a longer time. The probably most important and influential step was presumably 
the laser microdissection, where the tissue stayed out at room temperature due to the procedure. Some 
tissues were easy to cut, others needed to be cut several times till it was possible to take the excised 
part out. Frozen tissue still contains RNases, which become active as the tissue thaws [43]. Therefore, 
the quicker the microdissection, the better for RNA. Further, there were differences between the 
samples themselves. Some contained nice areas of stroma without any unwanted cells, in others just 
very little stroma was found, or it contained lots of glands and hair follicles that made excision more 
difficult and cumbersome. Nevertheless, suitable amounts of mRNA could be extracted to send for 
sequencing. During NGS several samples were excluded due to insufficient performance in during the 
run. Still, enough data was generated to analyse gene expression comparing CAS and normal stroma 
from control and KO mice. 
 
7.2.2 Gene expression analysis in CAS comparing KO and control mice 
Unsupervised hierarchical clustering of CAS from control and KO animals (Figure 13) showed clear 
differences in gene expression, with a total of 473 deregulated genes in KO compared to control. Results 
from gene ontology analysis suggest that these differences are likely to be linked to increased tumour 
growth and metastasis, as for instance cell adhesion is one main category found within the deregulated 
biological processes in Cluster 1(Figure 14) and integrin binding within the deregulated molecular 
functions (Figure 15) which are both strongly connected to cancer invasion and metastasis [44]. Other 
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categories among the deregulated biological processes are connected to steroid biosynthetic processes 
or steroid hormone mediated signalling pathways (Figure 14, Cluster 5 and 6). This is interesting, for it 
is known that steroids play a role in cancer development and metastasis [45, 46] [Haslam, 2001, Breast 
Cancer Res.]. Furthermore, this also suggests that the differences in gene expression found in our 
experiments are connected to the macroscopic findings of increased tumour growth and metastasis that 
were observed in these mice. Furthermore, we had a quick scan through the top 50 up- and top 50 
down-regulated genes, where several types of collagens were found among the up-regulated targets. 
Increased collagen deposition and crosslinking is one of the mainstay features of CAS that is secreted 
by CAFs and supports the invasion of cancer cells [5, 36-40], and an increase in collagen expression has 
been associated with a higher risk of metastasis in humans [47] and dogs [48]. Importantly also, 
deregulation of many collagens has been observed repeatedly in our laboratory using the XRCC1 KD 
fibroblast model in vitro (data not shown), which further supports XRCC1 depletion in fibroblasts as 
the driving force behind the observed changes.  
In summary we were able to show that there are molecular changes associated with cancer growth and 
metastasis in the tumour stroma of mice with a stromal XRCC1 depletion compared to control mice. 
However, due to lack of time, no detailed analysis was made thus far. Nevertheless, the obtained data 
is very promising for future investigations. 
 
7.2.3 Gene expression analysis in normal unaffected stroma in KO and control 
mice 
In addition to the comparison on CAS between the two groups of KO and control animals we also 
extracted mRNA from normal, non-tumour-associated stroma from the same mouse model. The 
unsupervised hierarchical clustering of normal stroma from control and KO animals reveals much less 
differentially expressed genes and overall larger variations between the samples of the two groups 
(Figure 16). Since CAFs are known to strongly interact with and be influenced by cancer cells, less effect 
was assumed in the absence of this interplay. This possibly explains the absence of huge changes in 
these samples of normal skin, as here fibroblasts are not interacting with tumour cells. Again, due to 
time restrictions, there unfortunately was no time for a closer investigation of the data, but it lays a 
good basis for future research. 
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7.2.4 Conclusion 
To conclude, we come back to the two main questions asked at the beginning: 
 
1. Does XRCC1 depletion in fibroblasts induce changes that support their survival in restricted 
growth conditions? If yes, is this dependent on the stress-responsive transcription factor ATF4? 
 
We have demonstrated that XRCC1 KD cells have a clear survival advantage under nutrient-restricted 
growth conditions by analysing cell morphology and density. The findings were validated by RT-qPCR 
and Western blot, showing that the KD was consistent in all the conditions. Furthermore, we were also 
able to show that these survival advantages depend on the upregulation of ATF4 by a co-knockdown 
of XRCC1 and ATF4, which resulted in a rescue of the observed phenotype in XRCC1 KD cells. 
Taking the investigation a step further by analysing cell cycle phases of control and XRCC1 KD cells 
grown in 15%, 5% or 1% FCS conditions, we found that the advantage of XRCC1 KD cells is likely due 
to an increased resistance to apoptosis. Because no increase in S-phase but rather a prolonged G1 phase 
was discovered in XRCC1 KD cells compared to control. To further support this hypothesis, it will be 
necessary to address the exact mechanism by which ATF4 imparts survival of XRCC1 KD cells in 
nutrient-starved conditions. Detailed understanding of the role of ATF4 in CAS has the potential to 
identify novel therapeutic approaches to target CAS. 
 
2. What molecular changes can be observed in the tumour stroma of mice with a stromal XRCC1 
depletion? How do these changes support tumour growth and metastasis? 
 
We successfully isolated mRNA from the desired tissue and performed Next-generation Sequencing. 
From the generated data we see that there are differences in gene-expression between CAS from control 
and KO mice and less so in normal stroma. Considering that CAFs are known to interact with cancer 
cells, that were absent in normal tissue, this was not unexpected. Furthermore, a first evaluation of the 
data suggests that the observed differences in gene expression could well be connected to the observed 
increase in tumour growth and metastasis. The generated data allows more detailed investigations of 
the molecular changes found in tumour stroma and as it will also be possible to identify interesting 
deregulated targets, this could help in understanding how the changes support tumour growth and 
metastasis. 
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